Capula Management »

Corvus Pharmaceuticals shares owned by Capula Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Capula Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $47k 15k 3.18

More positions owned by Capula Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Strategy Cl A New Put Option (MSTR)
UnitedHealth Put Option (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Coinbase Global Com Cl A Call Option (COIN)
Apple (AAPL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Nike CL B (NKE)
Dell Technologies CL C (DELL)

View all positions for Capula Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Point72 Asset Management
BlackRock
Vanguard Group
Adams Street Partners
Rtw Investments
Vivo Capital
Foresite Capital Management VI
Geode Capital Management
Perceptive Advisors
State Street Corporation
Morgan Stanley
Northern Trust
Goldman Sachs Group
Sphera Funds Management

View all funds holding Corvus Pharmaceuticals